Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
Frontiers in Medicine|February 18, 2021
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective StudySavino Sciascia, Massimo Radin, Irene Cecchi, et al.International Journal of Cardiology|June 17, 2022
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-headAlice Barinotti, Massimo Radin, Irene Cecchi, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|March 21, 2025
Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case ReportsBettina C Geertsema-Hoeve, Massimo Radin, Savino Sciascia, et al.American Journal of Nephrology|July 13, 2017
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation StudyDario Roccatello, Savino Sciascia, Daniela Rossi, et al.Journal of Clinical Medicine|June 10, 2022
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric ExperienceSavino Sciascia, Alice Barinotti, Massimo Radin, et al.Life (Basel, Switzerland)|May 4, 2026
Beyond the Usual Suspects: IgG4-Related Disease as a Rare Culprit in Cardiac Valvular DisordersPiera Costanzo, Savino Sciascia, Giacomo Quattrocchio, et al.European Journal of Rheumatology|February 6, 2020
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature reviewGregory Winston Gilcrease, Dario Padovan, Enrico Heffler, et al.Clinical and Experimental Rheumatology|October 28, 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocolSavino Sciascia, Massimo Radin, Irene Cecchi, et al.Frontiers in Immunology|March 29, 2024
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentationIrene Cecchi, Massimo Radin, Alice Barinotti, et al.Kidney Medicine|February 2, 2026
Caveolin-1 as a Marker of Endothelial Damage in Primary Antiphospholipid Syndrome NephropathySavino Sciascia, Massimo Radin, Irene Cecchi, et al.Pageof 12